Constipation • Intestinal transit • Anti-inflammatory • Reduction of gastro-intestinal discomfort • Inhibition of pathogenic E. coli • Restoration of a better dietary ω-6/ω-3 balance • Conjugated linoleic acids (CLA) production • Prospective use in the treatment of obesity • Cystitis • Inhibition of E. coli • Oxalate degradation • Reduction of intestinal inflammation • Potential reduction …
Inhibition of pathogens E. coli and Enterobacteriaceae
Gumtastic is a probiotic complex designed by SynBalance, it focuses on the protection from oral pathogens as S. mutans and A. actinomycetemcomitans as well as support overall gum health.
SmilinGut is a probiotic complex by SynBalance, specifically designed to support gastrointestinal health.SmilinGut has been clinically tested in a randomized double blind placebo controlled clinical trial. 100 IBS-C subjects were randomly divided in two group 50 supplemented with a daily dose of 6B/ day for 60 days + 30 days of follow-up and 50 supplemented …
Gaseous colic • Inhibition of E. coli, including toxinogenic O157:H7 • Inhibition of Klebsiella pneumoniae and of different coliforms isolated from colicky infants • Inhibition of pathogens E. coli, Klebsiella and gas-producing coliforms
Inhibition of pathogenic Candida species • Restoration of a physiological gut barrier • Inhibition of Candida growth • Strain from brushing of the gut mucosa
Inhibition of pathogenic Candida species • Vaginal health • Inhibition of Candida strains • Counteraction of vulvovaginal candidiasis (VVC)
Inhibition of E. coli
Constipation • Intestinal transit • Leaky gut • Inhibition of E. coli• Antioxidant activity • Reduced glutathione (GSH) and superoxide dismutase (SOD) production • Cystitis • Inhibition of E. coli • Oxalate degradation • Reduction of intestinal inflammation • Potential reduction of kidney stones incidence
Cystitis • Inhibition of E. coli
Anti-pathogen activity
Production of reuterin and vitamin B12 • Anti-pathogen activity and immunostimulation (induction of IFN-gamma) • Oxalate degradation • Reduction of intestinal inflammation • Potential reduction of kidney stones incidence
Diarrhea • Inhibition of E. coli, including enterohemorrhagic O157:H7 • Cystitis • Inhibition of E. coli
Inhibition of E. coli • Antioxidant activity • Reduced glutathione (GSH) and superoxide dismutase (SOD) production
Inhibition of Enterococcus faecalis, Enterococcus faecium and Neisseria gonorrhoeae • Vaginal health • Prevention of urogenital infections • Inhibition of Candida
Bifidobacterium animalis subsp. lactis BL050 (DSM 25566), developed by SynBalance.Gastrointestinal Health • Urogenital health • Metabolic Health• Immune prevention
MicrobiomeHUB is a space that brings together the companies of the microbiome industry
Brought to you by Clorofilla Scientific Publishing
This communication is only intended for business-to-business and health care professionals.
This communication is not intended for consumers of final consumer goods.
Nothing on this page is meant to be perceived as an approved claim.
Via Podgora 12/A, 20122, Milan, Italy – VAT: IT05299040963
© ALL RIGHTS RESERVED
